1676-P: Glucagon Receptor Blockade REMD-77 Further Improves Fasting Hyperglycaemia after Bariatric Surgery, But Reduces Hepatic Fatty Acid Oxidation
Amalia Gastaldelli(National Research Council), Marzieh Salehi, SILVIA SABATINI, Geltrude Mingrone(University of the Sacred Heart), Giulia Angelini(Università Cattolica del Sacro Cuore), Samantha Pezzica(Istituto di Fisiologia Clinica), Sara Russo(Università Cattolica del Sacro Cuore), Fabrizia Carli(Istituto di Fisiologia Clinica)
Cited by 0
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k